Researchers from The University of Osaka have found that rituximab, a monoclonal antibody approved for the treatment of nephrotic syndrome in children in Japan, also improves disease management in ...
Primary Mediastinal Large B-Cell Lymphoma: A Clinicopathologic Study of 43 Patients From the Nebraska Lymphoma Study Group PURPOSE: Rituximab was recently approved for use in relapsed, low-grade ...
The U.S. Food and Drug Administration (FDA) has approved Epkinly (epcoritamab-bysp) plus Revlimid (lenalidomide) and Rituxan ...
News Medical on MSN
Rituximab Prevents Relapse in Adult-Onset Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome: JAMA
One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
One monoclonal antibody, rituximab, can work wonders for the treatment of children with frequently relapsing nephrotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback